• Julphar previously held a 40% stake in the pharmaceutical wholesaler and retail chain. • The deal is expected to boost shareholder value by delving into new business lines and capturing greater market share. • The deal will add to Julphar's bottom-line numbers from the 2021 third quarter.
Gulf Pharmaceutical Industries Julphar picks up third place in the Government Institutions Championship in Ras Al Khaimah.
The first edition of the Government Institutions Football Championship, organized by Ras Al Khaimah University of Medicine and Health Sciences has been concluded, which was held from May 27-31, with the…
Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, today reported its financial results for the first quarter ending March 31,…